期刊文献+

凝血四项检测对于肝硬化患者的临床意义 被引量:1

下载PDF
导出
摘要 目的:探讨凝血四项检测[包括血浆凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)和纤维蛋白原的含量(FIB)]对于肝硬化患者的临床意义。方法:使用北京普利生血凝仪对36例肝硬化患者(观察组)和30例体格健康的志愿者(对照组)进行凝血四项检测。检测结果出来后,比较两组成员的检测结果。结果:肝硬化患者的血浆凝血酶原时间、活化部分凝血活酶时间和凝血酶时间较志愿者的这几个时间均明显延长(P<0.01),肝硬化患者的纤维蛋白原含量较志愿者的这项含量明显减少(P<0.01)。结论:定期进行凝血四项检测对肝硬化患者的用药和预后判断具有重要的意义。
出处 《求医问药(下半月刊)》 2011年第6期208-208,207,共2页 Seek Medical and Ask The Medicine
  • 相关文献

参考文献2

二级参考文献15

  • 1Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end- stage liver disease. Hepatology, 2001,33: 464-470.
  • 2Ishikawa M, Yogita S, Miyake H, et al. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.Hepatogastroenterology, 2002, 49: 1625-1631.
  • 3Schepis F, Camma C, Niceforo D, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology, 2001, 33: 333-338.
  • 4Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003,52: 134-139.
  • 5Robert A, Chazouilleres O. Prothrombin time in liver failure: time,ratio, activity percentage, or international normalized ratio? Hepatology, 1996, 24: 1392-1394.
  • 6Cui R, Wang B, Ding H, et al. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Chin Med J (Engl), 2002, 115: 42-45.
  • 7Naraki T, Kohno N, Saito H, et al. gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin. Biochim Biophys Acta, 2002, 1586: 287-298.
  • 8Izumi S, Langley PG, Wendon J, et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology,1996, 23: 1507-1511.
  • 9Rodriguez-Inigo E, Bartolome J, Quiroga JA, et al. Expression of factor Ⅶ in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis. Blood Coagul Fibrinolysis, 2001, 12: 193-199.
  • 10Manzano ML, Arocena C, Tomas JF, et al. Measurement of the procoagulant activity of factor Ⅶ in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk. Blood Coagul Fibrinolysis, 2000, 11(Suppl 1): S95-99.

共引文献14085

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部